| Literature DB >> 35111331 |
Ashley Cha Yin Lim1,2, Pragadesh Natarajan1,3,4, R Dineth Fonseka1,3,4, Monish Maharaj1,3,4, Ralph J Mobbs1,3,4.
Abstract
BACKGROUND: The purpose of this scoping review was to explore the current applications of objective gait analysis using inertial measurement units, custom algorithms and artificial intelligence algorithms in detecting neurological and musculoskeletal gait altering pathologies from healthy gait patterns.Entities:
Keywords: Gait-altering pathology; artificial intelligence; classification models; machine learning; musculoskeletal disease; neurological disease; wearable devices
Year: 2022 PMID: 35111331 PMCID: PMC8801637 DOI: 10.1177/20552076221074128
Source DB: PubMed Journal: Digit Health ISSN: 2055-2076
Figure 1.Flow diagram of selection and screening of included studies from databases and registers.
Search strategy.
| Objective gait analysis | Wearable device | Gait-altering pathologies | |
|---|---|---|---|
| 1. exp Gait/(30,209) | 4. exp Wearable Electronic Devices/ (12,883) | Neurological: | Musculoskeletal: |
Study populations of included studies.
| Authors | Algorithm type | Pathology | Sample size (male/female) | Mean age (years ± SD) |
|---|---|---|---|---|
| Buckley et al.
| Custom algorithm | Early-stage Parkinson disease | 70 (47M/23F) | 69.2 ± 9.9 |
| Age-matched controls | 64 (35M/29F) | 71.6 ± 6.8 | ||
| Fino et al.
| Custom algorithm | Suffered a sports-related concussion SRC within 48 h | 24 (18M/6F) | 20.3 |
| Age, gender, height and mass-matched controls. | 25 (19M/6F) | 20.9 | ||
| Ilg et al.
| Custom algorithm | Degenerative cerebellar ataxia (DCA) | 43 (23M/20F) | 51 ± 15 |
| Healthy controls | 35 | 48 ± 15 | ||
| Mc Ardle et al.
| Custom algorithm | Mild cognitive impairment/dementia due to Alzheimer disease | 32 | 77 ± 6 |
| Dementia with Lewy bodies | 28 | 76 ± 6 | ||
| Parkinson disease | 14 | 78 ± 6 | ||
| Simila et al.
| Custom algorithm | Older adults, independent and no cognitive incapability | 35 (0M/35F) | 73.8 |
| Stack et al.
| Custom algorithm | Patients with and without Parkinson | 24 (5M/19F) (10 with Parkinson) | 74 ± 8 |
| Tesconi et al.
| Custom algorithm | Vascular disease | 5 (1M/4F) | 73 |
| Healthy controls | 4 (3M/1F) | 32 | ||
| Zhang et al.
| Custom algorithm | Post-stroke patients | 16 (9M/7F) | 54 |
| Healthy controls | 9 (5M/4F) | 35 | ||
| Zhou et al.
| Custom algorithm | Haemodialysis patients with diabetes and end-stage renal disease | 44 (25M/19F) | 61.8 ± 6.7 |
| Cognitively-impaired patients | 25 (6M/19F) | 68.1 ± 8.8 | ||
| De Vos et al.
| Artificial intelligence | Progressive supranuclear palsy | 21 | 71 |
| Parkinson disease | 20 | 66.4 | ||
| Controls | 39 | 67.1 | ||
| Di Lazzaro et al.
| Artificial intelligence | Parkinson disease: tremor-dominant, postural instability gait difficulties, mixed phenotype | 36 | 63 |
| Controls | 29 | 69 | ||
| Hsu et al.
| Artificial intelligence | Stroke, brain concussion, spinal injury, brain haemorrhage | 11 | 65.2 |
| Controls | 9 | 66.4 | ||
| Jung et al.
| Artificial intelligence | Semi-professional athlete | 29 | 52.92 ± 9.6 |
| Patients with foot deformities | 21 | 27.9 ± 3.1 | ||
| Controls | 19 | 29.18 ± 4.89 | ||
| Kashyap et al.
| Artificial intelligence | Cerebellar ataxia (CA) | 23 (12M/11F) | 65 ± 11 |
| Controls | 11 (6M/5F) | 58 ± 12 | ||
| Mannini et al.
| Artificial intelligence | Post-stroke patients (PS) | 15 (10M/5F) | 61.3 ± 13 |
| Huntington disease patients (HD) | 17 (10M/7F) | 54.3 ± 12.2 | ||
| Controls | 10 (4M/6F) | 69.7 ± 5.8 | ||
| Moon et al.
| Artificial intelligence | Parkinson disease | 524 | 66.73 ± 9.17 |
| Essential tremor (ET) | 43 | 66.98 ± 9.84 | ||
| Nukala et al.
| Artificial intelligence | Patients with balance disorders | 4 | N/A |
| Controls | 3 | N/A | ||
| Rastegari
| Artificial intelligence | Mild Parkinson disease | 10 (5M/5F) | 63.8 ± 9.3 |
| Controls | 10 (5M/5F) | 64 ± 8.4 | ||
| Rehman et al.
| Artificial intelligence | Mild Parkinson disease | 93 (59M/34F) | 69.2 ± 10.1 |
| Controls | 103 (49M/54F) | 72.3 ± 6.7 | ||
| Rovini et al.
| Artificial intelligence | Idiopathic hyposmia (IH) | 30 (21M/9F) | 66 ± 3.2 |
| Parkinson disease | 30 (25M/5F) | 67.9 ± 8.8 | ||
| Controls | 30 (25M/5F) | 65.2 ± 2.5 | ||
| Steinmetzer et al.
| Artificial intelligence | Motor dysfunction (MD) | 15 | N/A |
| Controls | 24 | N/A | ||
| Tedesco et al.
| Artificial intelligence | Post-ACL athletes (rugby players) | 6M | 29.3 ± 4.5 |
| Controls | 6M | 22.8 ± 3.7 |
Wearable devices employed by included artificial intelligence studies.
| Authors | Device | Location of device | Number of devices | Sampling frequency |
|---|---|---|---|---|
| Buckley et al.
| OpalTM, APDM Inc, Portland, OR, USA | 5th lumbar vertebra, Back of the head | 2 | 128 Hz |
| Fino et al.
| Opal v1, APDM, Inc. Portland, OR USA | Forehead, lumbar spine, bilateral anterior distal region of shank. | 4 | 128 Hz |
| Ilg et al.
| Opal, APDM, Inc. Portland, WA | Both feet, posterior trunk at the level of L5. | 3 | N/A |
| Mc Ardle et al.
| Accelerometer-based wearable (AX3, Axivity, York, UK) | L5 | 1 | 100 Hz |
| Simila et al.
| Accelerometer (GCDC X16-2) | Centre of lower back between L3-L5, anterior right hip | 2 | 100 Hz |
| Stack et al.
| Tri-axial wearable sensors containing accelerometers and gyroscopes (2000° at 0.06 dps resolution) | Waist, ankles, wrists | 5 | N/A |
| Tesconi et al.
| Sensorised shoe, knee band KB and on body | Pressure sensors placed on the sole of the shoe near the heel | 2 | N/A |
| Zhang et al.
| 3D accelerometers (MTw, Awinda, Xsens, Enschede, The Netherlands) | Midline of lower back L3 and each foot | 3 | 100 Hz (resampled to 200 Hz using linear interpolation) |
| Zhou et al.
| Wearable sensors (LegSysTM, BioSensics LLC., MA, USA) | Lower back and dominant front lower shin for standing balance task. Sensors on both lower shin for supervised walking. Sensors worn in front of the chest for unsupervised walking | Standing balance task and gait task: 2; unsupervised gait: 1 | 50 Hz |
| De Vos et al.
| OpalTM, APDM, Portland, USA | Lumbar spine, right arm, right foot | 6 | 100 Hz |
| Di Lazzaro et al.
| Movit (Captiks Srl, Rome Italy) | Hands (tremor, RAHM), thighs (LA), feet (HTT) calves and trunk (PT), arms and trunk (TUG) | 9 | 50 Hz |
| Hsu et al.
| Delsys Trigno (Delsys Inc., Boston, MA, USA) | Lower back (L5) and both sides of the thigh, distal tibia (shank), and foot | 7 | 148 Hz |
| Jung et al.
| Xsens MVN, Enschede, Overijssel, the Netherland | Posterior pelvis, both thighs, both shanks, both feet | 7 | N/A |
| Kashyap et al.
| InvenSense, Inc., San Jose, CA, USA Design Chipset “MPU-9150” | 10 cm from the mouth, dorsum of hand, wrist, 1.5 m from the subject, dorsum of the foot, xiphisternum, midline upper back, both ankles | 1 (one device for multiple settings) | 50 Hz |
| Mannini et al.
| IMU (Opal, APDM, Inc., Portland, OR, USA) and Gait pressure mat (GAITRite TM Electronic Walkway, CIR System Inc., Franklin, NJ, USA) | Both shanks (20 mm above the malleoli), lumbar spine between L4 and S2 | 3 | 128 Hz (IMUs), 120 Hz (walkway) |
| Moon et al.
| Opal, APDM, Inc., Portland, OR, USA | On dorsal side of wrists, dorsal side of feet metatarsals, sternum, L5 lumbar | 6 | 128 Hz |
| Nukala et al.
| Texas Instruments, Dallas, TA, USA | T4 at the back | 1 | 160 Hz |
| Rastegari
| SHIMMER | Left and right ankle | 2 | 102 Hz |
| Rehman et al.
| Tri-axial accelerometer (BSN Medical Limited, Hull, UK), instrumented mat (Platinum model GAITRite) | Lower back L5 | 1 | tri-axial accelerometer (100 Hz), instrumented mat (240 Hz) |
| Rovini et al.
| SensFoot V2 | Dorsum of foot | 1 | 100 Hz |
| Steinmetzer et al.
| Meta motion rectangle wearable sensors from Mbientlab | Wrists | 2 | 100 Hz |
| Tedesco et al.
| Custom made | (1) Anterior tibia, 10 cm below the tibial tuberosity; | 4 (2 per leg) | 100 Hz |
Figure 2.Artificial intelligence models employed by included studies.
Figure 3.Increasing research interest in artificial intelligence-driven gait-analysis.
Walking bout of included studies.
| Authors | Task | Environment | Speed | Distance or time |
|---|---|---|---|---|
| Buckley et al.
| Gait task | Supervised clinical environment. Level surface. | Self-selected | 2 min around a 25 m circuit |
| Fino et al.
| Gait task | Supervised clinical environment. Level Surface. Varied testing location. | Self-selected | 2 min |
| Ilg et al.
| Gait task | (1) Supervised walking. Level surface; | Self-selected | (1) 50 m; |
| Mc Ardle et al.
| Gait task | Supervised clinical environment. Level surface | Self-selected | 6 × 10 m |
| Simila et al.
| Berg Balance Scale BBS, Timed-Up and Go-test TUG, five times sit to stand test STS-5, 2 × 20 m walk | Home environment | Self-selected | 2 × 20 m for gait task |
| Stack et al.
| (1) Chair transfer; | Supervised clinical environment and home environment | Self-selected | 3 m for gait task |
| Tesconi et al.
| Gait task | Supervised clinical environment. | Self-selected | 5 gait-cycle |
| Zhang et al.
| 15 m to 25 m walkway with 90 degree turns (6MWT) | Supervised clinical environment. Level surface. | Self-selected | 6 min |
| Zhou et al.
| (1) Standing balance task; | Supervised and unsupervised environment | Self-selected | 15 m |
| De Vos et al.
| (1) Gait task; | Straight and level surface | Self-selected | 2 min |
| Di Lazzaro et al.
| Rest tremor, | Clinical environment | Unspecified | Unspecified |
| Hsu et al.
| First-two strides of forward direction walk | Level surface | Self-selected | 6 trials of 12 m |
| Jung et al.
| Gait task | Clinical environment, straight path | (1) Self-selected; | 20 m |
| Kashyap et al.
| Speech: repeated syllable utterance SPE; | Clinical environment, level surface | Self-selected | 10 × 5 m (for gait test) |
| Mannini et al.
| Gait task | Clinical environment, level surface (12 m walkway) | Self-selected | 1 min |
| Moon et al.
| Instrumented stand and walk test (stand for 30 s, walk 7 m, 180° turn and walk 7 m back) | Clinical environment, level surface | Self-selected | 14 m |
| Nukala et al.
| (1) Level surface; | Clinical environment | Test 2: different gait speed; | N/A |
| Rastegari
| Walk 10 m four times on an obstacle free environment, turn around after each 10 m | Clinical environment, level surface, obstacle-free | Self-selected | 4 × 10 m |
| Rehman et al.
| (1) 4 × 10 m walkway (intermittent walk-IW); | Clinical environment, level surface | Self-selected | (1) 4 × 10 m; |
| Rovini et al.
| All motor tasks were performed twice. Once for R foot, once for L foot. | Clinical environment | (1) Fast speed; | (1) and (2) for 10 s; |
| Steinmetzer et al.
| TUG | Clinical environment | Self-selected | 2 × 10 m |
| Tedesco et al.
| Run for 5 m, sidestep left or right (for 45° angle), then run for 3 m. Repeat the test for 10 times. | Clinical environment | Maximum speed | 10 × 8 m |
Characteristics of included artificial intelligence studies of custom algorithms.
| Authors | Study objectives | Sensors | Algorithm or model | Variables | Model accuracy | Quality assessment score |
|---|---|---|---|---|---|---|
| Buckley et al.
| To find out whether changes in upper body motion (accelerations) during gait is a predictor of early PD. | Pressure-sensitive mat, inertial sensors | Univariate regression analysis, multivariate regression analysis | Spatiotemporal characteristics, upper body accelerations | Univariate AUC: 0.70–0.81; Multivariate AUC: 0.88–0.91 | 8.5 |
| Fino et al.
| To examine whether horizontal head turns when seated or walking have the clinical utility for diagnosing acute concussion. | Inertial sensors | Linear mixed models (LMMs) | Gait speed, peak head angular velocity, peak head angle, response accuracy, clinical balance | Peak head angular velocity: 0.7 < AUC < 0.8; peak head angle: 0.6 < AUC < 0.7 | 8.0 |
| Ilg et al.
| To identify gait features that allow quantification of ataxia-specific gait features in real life (participants with cerebellar ataxia). | Inertial sensors | Kruskal-Wallis test, Mann-Whitney | Stride variability, lateral step variability | Lateral step deviation and a compound measure of spatial step variability: 0.86 accuracy | 9.0 |
| Mc Ardle et al.
| To differentiate dementia subtypes (AD, DLB, PDD) using gait analysis. | Inertial sensors, instrumented walkway | One-way analysis of variance (ANOVA), Kruskal-Wallis test | Pace, Variability, Rhythm, Asymmetry, Postural Control | Wearable sensors: 7 out of 14 gait characteristics; instrumented walkway: 2 out of 14 gait characteristics showed significant group differences | 9.5 |
| Simila et al.
| To predict early signs of balance deficits using wearable sensors. | Inertial sensors | Mann-Whitney U-test, fast Fourier transform (FFT) algorithm. Generalised linear models. Sequential forward floating selection (SFSS) method and ten-fold cross-validation | Step time, stride time | AUC 0.78 is predicting decline in total Berg Balance Scale (BBS) and 0.82 for one leg stance. | 8.0 |
| Stack et al.
| To evaluate the usability of wearable sensors in detecting balance impairments in people with parkinson Disease in comparison with traditional methods (observation). | Inertial sensors, video analyst | N/A | Stability, subtle instability (caution and near-falls), time taken, parkin activity scale (PAS) | Ratings agreed in 86/117 cases (74%) for both video analysts and wearable sensors data. ( | 7.5 |
| Tesconi et al.
| To investigate the possibility of using wearable sensors for monitoring flexion-extension of the knee joint during deambulation. | Knee-band, wearable sensor, and sensorised shoe | N/A | Voltage level (flexion-extension signals), irregularity parameter (gait discontinuity) | Central sensors: sensitivity 80% specificity 75%; lateral sensors: sensitivity 80% specificity 100% | 7.0 |
| Zhang et al.
| To differentiate post-stroke patients from healthy controls using wearable sensors and proposed gait symmetry index GSI. | Inertial sensors | Wilcoxon test; Cliff's delta; Spearman Correlation; Pearson correlation coefficient | Spatiotemporal parameters, foot pitch angular velocity | The proposed GSI of L3 has good discriminative power in differentiating post-stroke patients. | 8.5 |
| Zhou et al.
| To examine whether remotely monitoring mobility performance can help identify digital measures of cognitive impairments in haemodialysis patients. | Inertial sensors | Analysis of variance (ANOVA); Analysis of chi-squared, Analysis of covariance (ANCOVA), univariate and multivariate linear regression model, binary logistic regression analysis | Cumulated posture duration, daily walking performance, postural-transition | Highest AUC 0.93 model include demographics and all variables (accuracy of 85.5%) | 8.5 |
Characteristics of included artificial intelligence studies of machine learning models.
| Authors | Study objectives | Sensors | Algorithm or model | Classification accuracy model validation | Classification accuracy results | Quality assessment score (total score 12) |
|---|---|---|---|---|---|---|
| De Vos et al.
| To investigate the use of wearable sensors coupled with machine learning as a means of disease classification between progressive supranuclear palsy and Parkinson’s disease. | Inertial sensors | One-way-analysis of variance (ANOVA), independent | 10-fold cross validation | 93% (RF: PSP vs. HC), 88% (RF: PSP vs. PD), 93% (LR: PSP vs. HC), 80% (LR: PSP vs. PD) | 10.0 |
| Di Lazzaro et al.
| To assess motor performances of a population of newly diagnosed, drug-free Parkinson’s disease (PD) patients using wearable inertial sensors and to compare them to healthy controls and differentiate PD subtypes (tremor dominant, postural instability gait disability and mixed phenotype). | Inertial sensors | ReliefF ranking, Kruskal-Wallis feature-selection methods, SVM, one-way ANOVA | Leave-one-out cross-validation | 97% (0.96) | 7.5 |
| Hsu et al.
| To conduct a comprehensive analysis of the placement of multiple wearable sensors for the purpose of analysing and classifying the gaits of patients with neurological disorders. | Inertial sensors | RF, neural network with multilayer perceptron, Gaussian Naïve Bayes, Adaboost, decision tree | 5-fold cross validation | 81% (RF), 78% (MP), 87% (NB), 84% (AB), 80% (DT) | 9.0 |
| Jung et al.
| To develop and evaluate neural network-based classifiers for effective categorization of athlete, normal foot, and deformed foot groups’ gait assessed using wearable IMUs. | Inertial sensors | Neural network-based classifier (using gait spectrograms) CNN | 4-fold cross-validation | Neural network Gait parameters: 93.02%. Gait spectrograms of foot (88.82%); post pelvis (94.25%); foot and post pelvis (96.68%); foot, shank, thigh, post pelvis (98.19%) | 8.0 |
| Kashyap et al.
| The study examines the potential use of a comprehensive sensor-based approach for objective evaluation of cerebellar ataxia in five domains (speech, upper limb, lower limb, gait and balance) through the instrumented versions of nine bedside neurological tests. | Inertial sensors, Kinect depth camera | RF, principal component analysis (PCA) | Leave-one-out cross-validation, comparing mean squared errors MSE by classification of various leaf size (l) | Combined nine tests demonstrate performance accuracy: 91.17%; classifying principal components PC in decreasing order of importance, performance accuracy: 97.06%; RF 97% (F1 score = 95.2%) | 7.5 |
| Mannini et al.
| To propose and validate a general probabilistic modelling approach for the classification of different pathological gaits (healthy elderly, post-stroke patients, patients with Huntington disease). | Inertial sensors | Hidden Markov models (HMMs), SVM, majority voting (MV) classification | Leave-one-subject-out (LOSO) cross-validation | Overall accuracy: 66.7%; SVM classifier (HMM-based features only): 71.5%; SVM classifier (time and frequency domains only): 71.7%; SVM classifier (full feature): 73.3%; apply MV classifier with the full feature: 90.5% | 9.5 |
| Moon et al.
| To determine whether balance and gait variables obtained with wearable inertial motion sensors can be utilised to differentiate between Parkinson’s disease (PD) and essential tremor (ET) using machine learning. | Inertial sensors | Neural networks, SVM, k-nearest neighbour, decision tree, RF, gradient boosting, LR, dummy model | Accuracy, recall, precision, F1 score, 3 fold cross-validation with grid search strategy | Accuracy 0.65 (kNN) to 0.89 (NN); precision 0.54 (SVM, kNN, DT, LR) to 0.61(NN); recall 0.58 (DT) to 0.63 (kNN, GB), F1 score 0.53 (DT, LR) to 0.61 (NN) | 8.0 |
| Nukala et al.
| To accurately classify patients with balance disorders and normal controls using wearable inertial sensors using machine learning and to determine the best-performing classification algorithm. | Inertial sensors | Back propagation artificial neural network (BP-ANN), support vector machine (SVM), k-nearest neighbours algorithm (KNN), binary decision tress (BDT) | Confusion Matrix, sensitivity, specificity, precision, negative predictive value (NPV), F-measure | BP-ANN (100%), SVM (98%), KNN (96%), BDT (94%) | 7.0 |
| Rastegari
| To compare the bag-of-words approach with standard epoch-based statistical approach of feature engineering methods in Parkinson disease patients. | Inertial sensors | Linear SVM, decision tree, RF, k-nearest neighbour KNN | Leave-one-subject-out cross validation LOSOCV, Pearson correlation analysis | Bag of words approach (90%), epoch-based statistical feature (60%) | 7.0 |
| Rehman et al.
| To compare the impact of walking protocols and gait assessment systems on the performance of a support vector machine (SVM) and random forest (RF) for classification of Parkinson’s disease. | Inertial sensors | Multivariate analysis of variance (MANOVA), independent t-test, receiver operating characteristics analysis (ROC), SVM with radial basis function SVM-RBF, RF | 10-fold cross-validation with area under the curve AUC | SVM performed better than RF. Intermittent walkway (IW): no differences between Axivity and GAITRite; continuous walkway (CW): classification more accurate with Axivity (AUC 87.83) versus GAITRite (AUC 80.49) | 9.0 |
| Rovini et al.
| To accurately classify gait altering pathologies (healthy controls, Parkinson’s disease, idiopathic hyposmia) by performing comparative classification analysis using three supervised machine learning algorithms. | Inertial sensors | Kolmogorov-Smirnov test, Kruskal-Wallis test, Wilcoxon rank-sum test, Spearman correlation coefficient, SVM, RF, Naïve Bayes NB | Sensitivity, specificity, precision, accuracy, F-measure, 10-fold cross-validation | RF (0.97 accuracy); SVM (0.93 sensitivity, 0.97 specificity, 0.95 accuracy); NB (0.95 accuracy). SVM had the worst performance. | 6.5 |
| Steinmetzer et al.
| To determine whether arm swing could accurately classify patients with Parkinson’s disease using wearable sensors and machine learning algorithms. | Inertial sensors | Wavelet transformation, convolutional neural network CNN single signal, multi-layer CNN, weight voting | 3-fold cross-validation, binary confusion matrix | Three-channel CNN achieved the best results. classification accuracy of 93.4% using wavelet transformation and three-layer CNN architecture | 9.0 |
| Tedesco et al.
| To investigate the ability of a set of inertial sensors worn on the lower limbs by rugby players involved a change-of-direction (COD) activity to differentiate between healthy and post-ACL groups via the use of machine learning. | Inertial sensors | k-nearest neighbour kNN, Naïve Bayes NB, SVM, gradient boosting tree XGB, multi-layer perceptron MLP, stacking | Leave-one-out cross-validation LOSO-CV | Multilayer perception accuracy 73.07%; gradient boosting sensitivity 81.8%. Worst accuracy SVM 71.18%. The overall accuracy is uniform among all models (between 71.18% and 73.07%) | 9.5 |
Abbreviations : LR, Logistic Regression; RF, Random Forest; SVM Support Vector Machine; ANOVA, One-way-Analysis Of Variance.
CASP methodological quality assessment of studies of custom algorithms and machine learning models.
| Authors | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buckley et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 8.5 |
| Fino et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.5 | 0.5 | 0.5 | 1.0 | 0.5 | 1.0 | 1.0 | 0.5 | 8.0 |
| Ilg et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 9.0 |
| Mc Ardle et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 1.0 | 0.5 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 9.5 |
| Simila et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 8.0 |
| Stack et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 0.0 | 0.5 | 0.5 | 0.5 | 1.0 | 0.5 | 0.5 | 0.5 | 7.5 |
| Tesconi et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 0.5 | 1.0 | 0.5 | 1.0 | 0.5 | 0.5 | 0.5 | 7.0 |
| Zhang et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 1.0 | 0.5 | 8.5 |
| Zhou et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 8.5 |
| De Vos et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 1.0 | 10.0 |
| Di Lazzaro et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.0 | 7.5 |
| Hsu et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 9.0 |
| Jung et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 1.0 | 0.0 | 8.0 |
| Kashyap et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 0.0 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 7.5 |
| Mannini et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 9.5 |
| Moon et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 1.0 | 0.5 | 1.0 | 0.5 | 1.0 | 1.0 | 0.5 | 8.0 |
| Nukala et al.
| 1.0 | 0.0 | 0.5 | 0.5 | 0.0 | 1.0 | 1.0 | 0.5 | 0.5 | 1.0 | 1.0 | 0.0 | 7.0 |
| Rastegari
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 0.5 | 1.0 | 0.5 | 0.5 | 1.0 | 0.5 | 0.5 | 7.0 |
| Rehman et al.
| 1.0 | 1.0 | 1.0 | 0.5 | 0.5 | 1.0 | 0.5 | 1.0 | 0.5 | 0.5 | 1.0 | 0.5 | 9.0 |
| Rovini et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 0.0 | 0.5 | 0.5 | 0.5 | 0.5 | 1.0 | 0.5 | 0.5 | 6.5 |
| Steinmetzer et al.
| 1.0 | 1.0 | 0.0 | 1.0 | 0.0 | 1.0 | 1.0 | 1.0 | 0.5 | 1.0 | 0.5 | 1.0 | 9.0 |
| Tedesco et al.
| 1.0 | 0.0 | 0.5 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 0.5 | 1.0 | 1.0 | 1.0 | 9.5 |